當(dāng)前位置：首頁 JCRQ3 期刊介紹(非官網(wǎng))

Journal Of AntibioticsSCIE

國際簡稱：J ANTIBIOT 參考譯名：抗生素雜志

中科院分區(qū)
4區(qū)
CiteScore分區(qū)
Q2
JCR分區(qū)
Q3

基本信息：: ISSN：0021-8820; E-ISSN：1881-1469; 是否OA：未開放; 是否預(yù)警：否; TOP期刊：否

出版信息：: 出版地區(qū)：JAPAN; 出版商：Springer Nature; 出版語言：English; 出版周期：Monthly; 出版年份：2005; 研究方向：醫(yī)學(xué)-免疫學(xué)

評價信息：: 影響因子：2.1; H-index：73; CiteScore指數(shù)：6.6; SJR指數(shù)：0.546; SNIP指數(shù)：0.77

發(fā)文數(shù)據(jù)：: Gold OA文章占比：9.40%; 研究類文章占比：95.35%; 年發(fā)文量：86; 自引率：0.0303...; 開源占比：0.0745; 出版撤稿占比：0; 出版國人文章占比：0.19; OA被引用占比：0.0829...

投稿咨詢加急見刊

英文簡介期刊介紹 CiteScore數(shù)據(jù) 中科院SCI分區(qū) JCR分區(qū) 發(fā)文數(shù)據(jù) 常見問題

英文簡介Journal Of Antibiotics期刊介紹

The Journal of Antibiotics seeks to promote research on antibiotics and related types of biologically active substances and publishes Articles, Review Articles, Brief Communication, Correspondence and other specially commissioned reports. The Journal of Antibiotics accepts papers on biochemical, chemical, microbiological and pharmacological studies. However, studies regarding human therapy do not fall under the journal’s scope. Contributions regarding recently discovered antibiotics and biologically active microbial products are particularly encouraged. Topics of particular interest within the journal's scope include, but are not limited to, those listed below:

Discovery of new antibiotics and related types of biologically active substances

Production, isolation, characterization, structural elucidation, chemical synthesis and derivatization, biological activities, mechanisms of action, and structure-activity relationships of antibiotics and related types of biologically active substances

Biosynthesis, bioconversion, taxonomy and genetic studies on producing microorganisms, as well as improvement of production of antibiotics and related types of biologically active substances

Novel physical, chemical, biochemical, microbiological or pharmacological methods for detection, assay, determination, structural elucidation and evaluation of antibiotics and related types of biologically active substances

Newly found properties, mechanisms of action and resistance-development of antibiotics and related types of biologically active substances.

期刊簡介Journal Of Antibiotics期刊介紹

《Journal Of Antibiotics》自2005出版以來，是一本醫(yī)學(xué)優(yōu)秀雜志。致力于發(fā)表原創(chuàng)科學(xué)研究結(jié)果，并為醫(yī)學(xué)各個領(lǐng)域的原創(chuàng)研究提供一個展示平臺，以促進(jìn)醫(yī)學(xué)領(lǐng)域的的進(jìn)步。該刊鼓勵先進(jìn)的、清晰的闡述，從廣泛的視角提供當(dāng)前感興趣的研究主題的新見解，或?qū)彶槎嗄陙砟硞€重要領(lǐng)域的所有重要發(fā)展。該期刊特色在于及時報(bào)道醫(yī)學(xué)領(lǐng)域的最新進(jìn)展和新發(fā)現(xiàn)新突破等。該刊近一年未被列入預(yù)警期刊名單，目前已被權(quán)威數(shù)據(jù)庫SCIE收錄，得到了廣泛的認(rèn)可。

該期刊投稿重要關(guān)注點(diǎn)：

預(yù)計(jì)審稿時間：約2月
醫(yī)學(xué)
BIOTECHNOLOGY & APPLIED MICROBIOLOGY
SCIE
中科院4區(qū)
非預(yù)警

Cite Score數(shù)據(jù)（2024年最新版）Journal Of Antibiotics Cite Score數(shù)據(jù)

CiteScore：6.6
SJR：0.546
SNIP：0.77

學(xué)科類別	分區(qū)	排名	百分位
大類：Pharmacology, Toxicology and Pharmaceutics 小類：Pharmacology	Q2	104 / 313	66%
大類：Pharmacology, Toxicology and Pharmaceutics 小類：Drug Discovery	Q2	57 / 157	64%

CiteScore 是由Elsevier(愛思唯爾)推出的另一種評價期刊影響力的文獻(xiàn)計(jì)量指標(biāo)。反映出一家期刊近期發(fā)表論文的年篇均引用次數(shù)。CiteScore以Scopus數(shù)據(jù)庫中收集的引文為基礎(chǔ)，針對的是前四年發(fā)表的論文的引文。CiteScore的意義在于，它可以為學(xué)術(shù)界提供一種新的、更全面、更客觀地評價期刊影響力的方法，而不僅僅是通過影響因子(IF)這一單一指標(biāo)來評價。

歷年Cite Score趨勢圖

中科院SCI分區(qū)Journal Of Antibiotics 中科院分區(qū)

中科院 2023年12月升級版 綜述期刊：否 Top期刊：否

大類學(xué)科	分區(qū)	小類學(xué)科	分區(qū)
醫(yī)學(xué)	4區(qū)	BIOTECHNOLOGY & APPLIED MICROBIOLOGY 生物工程與應(yīng)用微生物 IMMUNOLOGY 免疫學(xué) MICROBIOLOGY 微生物學(xué) PHARMACOLOGY & PHARMACY 藥學(xué)	3區(qū) 4區(qū) 4區(qū) 4區(qū)

中科院分區(qū)表 是以客觀數(shù)據(jù)為基礎(chǔ)，運(yùn)用科學(xué)計(jì)量學(xué)方法對國際、國內(nèi)學(xué)術(shù)期刊依據(jù)影響力進(jìn)行等級劃分的期刊評價標(biāo)準(zhǔn)。它為我國科研、教育機(jī)構(gòu)的管理人員、科研工作者提供了一份評價國際學(xué)術(shù)期刊影響力的參考數(shù)據(jù)，得到了全國各地高校、科研機(jī)構(gòu)的廣泛認(rèn)可。

中科院分區(qū)表 將所有期刊按照一定指標(biāo)劃分為1區(qū)、2區(qū)、3區(qū)、4區(qū)四個層次，類似于“優(yōu)、良、及格”等。最開始，這個分區(qū)只是為了方便圖書管理及圖書情報(bào)領(lǐng)域的研究和期刊評估。之后中科院分區(qū)逐步發(fā)展成為了一種評價學(xué)術(shù)期刊質(zhì)量的重要工具。

歷年中科院分區(qū)趨勢圖

JCR分區(qū)Journal Of Antibiotics JCR分區(qū)

2023-2024 年最新版

按JIF指標(biāo)學(xué)科分區(qū)	收錄子集	分區(qū)	排名	百分位
學(xué)科：BIOTECHNOLOGY & APPLIED MICROBIOLOGY	SCIE	Q3	123 / 174	29.6%
學(xué)科：IMMUNOLOGY	SCIE	Q4	141 / 181	22.4%
學(xué)科：MICROBIOLOGY	SCIE	Q3	117 / 161	27.6%
學(xué)科：PHARMACOLOGY & PHARMACY	SCIE	Q3	210 / 354	40.8%

按JCI指標(biāo)學(xué)科分區(qū)	收錄子集	分區(qū)	排名	百分位
學(xué)科：BIOTECHNOLOGY & APPLIED MICROBIOLOGY	SCIE	Q3	104 / 174	40.52%
學(xué)科：IMMUNOLOGY	SCIE	Q3	110 / 181	39.5%
學(xué)科：MICROBIOLOGY	SCIE	Q3	90 / 161	44.41%
學(xué)科：PHARMACOLOGY & PHARMACY	SCIE	Q3	210 / 354	40.82%

JCR分區(qū)的優(yōu)勢在于它可以幫助讀者對學(xué)術(shù)文獻(xiàn)質(zhì)量進(jìn)行評估。不同學(xué)科的文章引用量可能存在較大的差異，此時單獨(dú)依靠影響因子(IF)評價期刊的質(zhì)量可能是存在一定問題的。因此，JCR將期刊按照學(xué)科門類和影響因子分為不同的分區(qū)，這樣讀者可以根據(jù)自己的研究領(lǐng)域和需求選擇合適的期刊。

歷年影響因子趨勢圖

發(fā)文數(shù)據(jù)

2023-2024 年國家/地區(qū)發(fā)文量統(tǒng)計(jì)

國家/地區(qū)數(shù)量
Japan164
CHINA MAINLAND99
USA70
South Korea25
GERMANY (FED REP GER)18
Thailand14
England11
Russia11
Canada10
India10

本刊中國學(xué)者近年發(fā)表論文

1、Drug repurposing strategy part 1: from approved drugs to agri-bactericides leads
Author: Ma, Yue; Wang, Yi-Rong; He, Ying-Hui; Ding, Yan-Yan; An, Jun-Xia; Zhang, Zhi-Jun; Zhao, Wen-Bin; Hu, Yong-Mei; Liu, Ying-Qian

Journal: JOURNAL OF ANTIBIOTICS. 2023; Vol. 76, Issue 1, pp. 27-51. DOI: 10.1038/s41429-022-00574-y
2、In vitro analysis of synergistic combination of polymyxin B with 12 other antibiotics against MDR Acinetobacter baumannii isolated from a Chinese tertiary hospital
Author: Liu, Hui; Hu, Dan; Wang, Dongxin; Wu, Han; Pan, Yunjun; Chen, Xin; Qi, Lin; Li, Lian; Liang, Rongxin

Journal: JOURNAL OF ANTIBIOTICS. 2023; Vol. 76, Issue 1, pp. 20-26. DOI: 10.1038/s41429-022-00573-z
3、Recent advances in the biosynthesis of ribosomally synthesized and posttranslationally modified peptides of fungal origin
Author: Ozaki, Taro; Minami, Atsushi; Oikawa, Hideaki

Journal: JOURNAL OF ANTIBIOTICS. 2023; Vol. 76, Issue 1, pp. 3-13. DOI: 10.1038/s41429-022-00576-w
4、Geninthiocins E and F, two new cyclic thiopeptides with antiviral activities from soil-derived Streptomyces sp. CPCC 200267 using OSMAC strategy
Author: Fang, Yuan; Wang, Jing; Tang, Yan; Guo, Zhe; Bai, Jinglin; Wu, Linzhuan; Su, Jing; Cen, Shan; Yu, Liyan; Zhang, Dewu

Journal: JOURNAL OF ANTIBIOTICS. 2023; Vol. 76, Issue 2, pp. 101-104. DOI: 10.1038/s41429-022-00580-0
5、Four new chromone derivatives from the Arctic fungus Phoma muscivora CPCC 401424 and their antiviral activities
Author: Tang, Yan; Gu, Guowei; Wang, Jing; Guo, Zhe; Zhang, Tao; Cen, Shan; Dai, Shengjun; Yu, Liyan; Zhang, Dewu

Journal: JOURNAL OF ANTIBIOTICS. 2023; Vol. 76, Issue 2, pp. 88-92. DOI: 10.1038/s41429-022-00588-6
6、Alkyl aromatic derivatives from the endophytic fungus Cytospora rhizophorae
Author: Zhang, Yanjiang; Liu, Hongxin; Chen, Yuchan; Liu, Zhaoming; Qiu, Kaidi; Wei, Shanshan; Zhang, Weimin; Tan, Haibo

Journal: JOURNAL OF ANTIBIOTICS. 2023; Vol. 76, Issue 3, pp. 121-130. DOI: 10.1038/s41429-022-00591-x
7、The potential target of bithionol against Staphylococcus aureus: design, synthesis and application of biotinylated probes Bio-A2
Author: Luo, Yue; Wen, Zewen; Xiong, Yanpeng; Chen, Xuecheng; Shen, Zonglin; Li, Peiyu; Peng, Yalan; Deng, Qiwen; Yu, Zhijian; Zheng, Jinxin; Han, Shiqing

Journal: JOURNAL OF ANTIBIOTICS. 2023; Vol. , Issue , pp. -. DOI: 10.1038/s41429-023-00618-x
8、Sulfoxanthicillin from the deep-sea derived Penicillium sp. SCSIO sof101: an antimicrobial compound against Gram-positive and -negative pathogens
Author: Yang, Jiafan; Song, Yongxiang; Zhou, Zhenbin; Huang, Yun; Wang, Songtao; Yuan, Jie; Wong, Nai-Kei; Yan, Yan; Ju, Jianhua

Journal: JOURNAL OF ANTIBIOTICS. 2023; Vol. 76, Issue 3, pp. 113-120. DOI: 10.1038/s41429-022-00593-9